Journal profile · Immunology
Clinical Immunology
ISSN 1521-6616 · eISSN 1521-7035 · Academic Press Inc. · UNITED STATES · Monthly · Founded 1999
Clinical Immunology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.08; hybrid open access; APC about USD 4,400; median 83 days to acceptance (100 articles, last 24 months); community-reported acceptance: about 25%; 153 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical Immunology is published by Academic Press Inc. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Immune Cell Function and Interaction, T-cell and B-cell Immunology and Immunodeficiency and Autoimmune Disorders, together about 36.9% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Clinical Immunology publishes original research on the molecular and cellular bases of immunological disease. The journal also features reviews of timely topics in basic immunology, case reports, and letters to the editor.Research Areas Include:Ageing Allergy Autoimmunity Biotechnology Clinical Laboratory Immunology HIV Immunodermatology Immunohematology Immunotoxicology/Environmental Infection and Immunity Mucosal Immunity Neuroimmunology Primary Immunodeficiency Transplantation Tumor Immunology Vaccines
From the journal's Aims & Scope
Research area (LetPub): Immunology
Editor-in-chief Samia KhouryPublisher website
Editorial board by country: 10 in mainland China (about 21%); most named United States 15, Mainland China 10, Japan 6, United Kingdom 3, Italy 3 (48 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immune Cell Function and InteractionImmunology and Microbiology14.8%
- T-cell and B-cell ImmunologyImmunology and Microbiology12.4%
- Immunodeficiency and Autoimmune DisordersImmunology and Microbiology9.7%
- Immunotherapy and Immune ResponsesImmunology and Microbiology7.9%
- Systemic Lupus Erythematosus ResearchMedicine5.9%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology4.9%
- Monoclonal and Polyclonal Antibodies ResearchMedicine4.4%
- Immune Response and InflammationImmunology and Microbiology4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.08LetPub ·
- Impact factor (publisher)
- 4.1Publisher website ·
- CiteScore 2026-06
- 7.8LetPub ·
- CiteScore (publisher)
- 7.8Publisher website ·
- SJR 2026-06
- 1.32LetPub ·
- SNIP 2026-06
- 0.96LetPub ·
- h-index
- 112LetPub ·
- h-index
- 166OpenAlex ·
- i10-index
- 3,617OpenAlex ·
- 2-year mean citedness
- 3OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 30.38%LetPub ·
Volume
- Articles per year
- 135LetPub ·
Articles by year OpenAlex count · 8,820 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 81 | 24 | 29 |
| 2025 | 153 | 61 | 377 |
| 2024 | 450 | 138 | 1,644 |
| 2023 | 666 | 154 | 3,675 |
| 2022 | 220 | 87 | 3,831 |
| 2021 | 184 | 85 | 4,231 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
83 daysMedian, submission to acceptance · P25–P75 59 days – 105 days
- Acceptance to online
- median 3 days (100 articles)
- Submission to online
- median 86 days
- Sample
- 100 articles with submission and acceptance dates (261 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- First decision after review
- 38 daysPublisher website ·
- Submission to acceptance
- 81 daysPublisher website ·
- Acceptance to publication
- 3 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,400 / EUR 4,120 / GBP 3,520 / JPY 545,730 | — | — | |
| Publisher website | USD 4,280 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 150 words
- Keywords
- ≥ 1
- Manuscript length
- ≤ 3,000 words
- Reference style
- Numbered, in order of citation
Article types accepted8, with length limits
- brief communicationJournal Article Publishing Support Hub. Brief Communication Brief Communication (of no more than 3000 words and two tables and/or figures) will be considered fo…main text ≤ 3,000 words
- editorials and meeting reportsEditorials and Meeting Reports These are published occasionally if they are directly relevant to the themes of the journal.Length not stated
- letters to the editorThese will be considered if they relate to articles published in the journal. They should be limited to 1000 words, contain no more than one figure or table, an…main text ≤ 1,000 words
- original articleThe chief criteria for acceptance of papers submitted for publication are the originality, clarity, and quality of the work reported. In preparing an article fo…Length not stated
- original articlesOriginal Articles The chief criteria for acceptance of papers submitted for publication are the originality, clarity, and quality of the work reported.Length not stated
- reviewReviews of 20 manuscript pages (double spaced or less, exclusive of references) are published monthly. Generally a maximum total of 4 figures/tables are include…figures and tables ≤ 4
- reviewsReviews of 20 manuscript pages (double spaced or less, exclusive of references) are published monthly.Length not stated
- symposia-in-writingSymposia-in-Writing Periodically, the journal publishes a collection of brief state-of-the-art essays based on a single topic, accompanied by an introduction by…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Publishing ethics policy Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Academic Press Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1999
- ISSN
- 1521-6616
- Electronic ISSN
- 1521-7035
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Clinical Immunology
What CAS zone is Clinical Immunology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical Immunology is in Zone 3 of Medicine, and in Zone 3 of the minor category Immunology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical Immunology?
The latest impact factor listed by LetPub is 4.08; CiteScore 7.8, h-index 166.
How long does peer review take at Clinical Immunology?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 83 days (interquartile range 59–105 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 25%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Clinical Immunology?
According to the journal's author guidelines: Abstract: ≤ 150 words; Keywords: ≥ 1; Manuscript length: ≤ 3,000 words; Reference style: Numbered, in order of citation. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Clinical Immunology based?
Of the 48 board members whose country the journal's board page names, 10 (about 21%) are in mainland China; the countries named most often are United States (15), Mainland China (10) and Japan (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical Immunology?
According to LetPub and DOAJ records, Clinical Immunology is indexed in SCIE and Scopus.
Is Clinical Immunology open access, and what is the APC?
Clinical Immunology is a hybrid journal. For open-access publication: APC about USD 4,400.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .